LOG-IN FARMA supera inspecciones sanitarias en Uruguay y habilita nuevo centro de distribución

0 comments

Log-In Farma Expands Pharmaceutical Logistics Capacity in Uruguay

The pharmaceutical logistics landscape in Latin America continues to evolve as companies seek to enhance the integrity of the medical supply chain. Recently, Log-In Farma, a specialized logistics provider for the human and veterinary health sectors, successfully completed a series of rigorous sanitary inspections in Uruguay. This milestone marks a significant step toward the full operational activation of the company’s new distribution center located within the Parque de las Ciencias in Uruguay’s Free Trade Zone.

Meeting High Regulatory Standards

Between May 13 and May 15, the facility underwent comprehensive audits conducted by the Dirección de Laboratorios Veterinarios (DILAVE) and the Ministerio de Salud Pública (MSP) of Uruguay. These regulatory bodies are responsible for ensuring that health-related infrastructure complies with strict national and international safety protocols.

The audits concluded without any critical observations, a testament to the facility’s adherence to Good Distribution Practices (GDP). This regulatory approval is essential for the company to move forward with its final certification process, enabling it to manage, store and distribute sensitive pharmaceutical and veterinary products across the region.

Strategic Infrastructure for Cold Chain Integrity

The new 10,000-square-meter facility was purpose-built to address the complex requirements of the modern pharmaceutical industry. In the context of medical logistics, infrastructure is not merely about storage space; it is about environment control. Key features of the new distribution hub include:

  • Advanced Cold Chain Management: Dedicated systems to maintain precise temperature ranges, critical for biologics, vaccines, and heat-sensitive medications.
  • Technological Integration: Automated inventory systems that ensure traceability and real-time monitoring of pharmaceutical stocks.
  • Strategic Connectivity: Located in the Parque de las Ciencias, the hub leverages Uruguay’s logistical connectivity to facilitate faster distribution across the Southern Cone.

Regional Growth and Institutional Backing

Log-In Farma is part of a business group led by Jonathan Kovalivker, which also includes Suizo Argentina. With over a century of experience in the healthcare sector, the group brings substantial institutional expertise to this expansion project. As Latin American countries increasingly utilize Free Trade Zones as regional hubs for drug distribution, this investment positions Log-In Farma to play a more prominent role in regional supply chain resilience.

Key Takeaways

  • Regulatory Success: Log-In Farma passed critical health audits in Uruguay, clearing the path for full operations.
  • Infrastructure: The 10,000 m² facility is specifically engineered for cold chain and pharmaceutical handling.
  • Regional Strategy: The expansion reflects a broader trend of centralizing pharmaceutical logistics in Latin American Free Trade Zones to improve regional access to medicine.

Frequently Asked Questions (FAQ)

What are Good Distribution Practices (GDP) in pharmaceuticals?

GDP guidelines ensure that the quality and integrity of medicines are maintained throughout the supply chain. This involves strict control over storage conditions, transportation, and documentation to prevent contamination or degradation.

LOG-IN FARMA | Operaciones logísticas con foco en la industria farmaceútica

Why are Free Trade Zones important for pharma logistics?

Free Trade Zones offer unique tax, customs, and logistical advantages that allow companies to store and redistribute products across international borders more efficiently, reducing both costs and delivery times.

How does cold chain logistics protect patients?

Many modern medications, particularly vaccines and monoclonal antibodies, are highly sensitive to temperature fluctuations. Without a robust cold chain, these products can lose their efficacy, potentially rendering them ineffective or even dangerous for the patient.


Disclaimer: This article is for informational purposes and does not constitute medical or financial advice. Always verify regulatory status through official government portals like the Uruguayan Ministry of Public Health.

Related Posts

Leave a Comment